Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    Welcome !
    My account
    Logout

Angion Biomedica Corp (ANGN) Stock Forecast 2025 - AI Price Prediction & Analysis

Angion Biomedica Corp (ANGN) AI Stock Price Forecast & Investment Analysis

Angion Biomedica Corp Stock Price Chart and Technical Analysis

Loading Angion Biomedica Corp interactive price chart and technical analysis...

Angion Biomedica Corp (ANGN) - Comprehensive Stock Analysis & Investment Research

Deep dive into Angion Biomedica Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Angion Biomedica Corp, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Angion Biomedica Corp: Angion Biomedica Corp operates in the Manufacturing sector, making it an emerging small-cap investment.

Angion Biomedica Corp (Stock Symbol: ANGN) is a leading company in the Manufacturing sector , specifically operating within the Pharmaceutical Preparation Manufacturing industry.

The organization employs approximately 3 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Angion Biomedica Corp's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Angion Biomedica Corp: With $2M in annual revenue and -1206.7% net margin, the company demonstrates developing profitability.

Annual Revenue: $2 million generating a -1206.7% net profit margin .

Market Capitalization: $301 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -40.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Angion Biomedica Corp stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Angion Biomedica Corp: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Angion Biomedica Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Angion Biomedica Corp's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Angion Biomedica Corp: Market positioning analysis based on available financial and operational metrics.

Angion Biomedica Corp strategically competes in the highly dynamic Pharmaceutical Preparation Manufacturing marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 16.1% gross margin, indicating strong pricing power and operational efficiency.

Angion Biomedica Corp (ANGN) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Angion Biomedica Corp stock analysis.

Loading Angion Biomedica Corp comprehensive fundamental analysis and insider trading data...

Deep dive into Angion Biomedica Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Angion Biomedica Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Angion Biomedica Corp: With a P/E ratio of -7.97, the market sees the stock as potentially undervalued.

P/E Ratio -7.97x
P/B Ratio 7.59x
Market Cap $301M
EPS $-1.14
Book Value/Share $1.32
Revenue/Share $-0.46
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Angion Biomedica Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Angion Biomedica Corp: An ROE of -40.3% indicates room for improvement in shareholder value creation.

ROE -40.3%
ROA -29.1%
ROIC -37.9%
Gross Margin 16.1%
Operating Margin -1292.6%
Net Margin -1206.7%
EBT Margin -108.6%
Tax Rate 26.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Angion Biomedica Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Angion Biomedica Corp: A current ratio of 7.34 indicates strong liquidity.

Current Ratio 7.34x
Quick Ratio 7.03x
D/E Ratio 0.05x
Financial Leverage 1.21x
Interest Coverage 6.8x
Working Capital $-65M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Angion Biomedica Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Angion Biomedica Corp: Free cash flow of $-56M indicates cash challenges that need attention.

Operating Cash Flow $-56M
Free Cash Flow $-56M
OCF Growth YoY 77.7%
FCF Growth YoY 84.3%
FCF/Sales -189.6%
CapEx/Sales 1.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Angion Biomedica Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Angion Biomedica Corp: An asset turnover of 0.27x suggests room for improvement in asset utilization.

Asset Turnover 0.27x
Receivables Turnover 70.3x
Fixed Assets Turnover 6.6x
Days Sales Outstanding 5 days
Payables Period 4336 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Angion Biomedica Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Angion Biomedica Corp: With annual revenue of $2M, Angion Biomedica Corp represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $2M
Operating Income $-29M
Net Income $-27M
R&D Expense $7M
SG&A Expense $57M
Cost of Goods Sold $-14M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 94%
Cash & Short-term Investments 90%
Total Liabilities 17%
Short-term Debt 109%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 30M
Growth Metrics (YoY)
EPS Growth -11.4%

Latest Angion Biomedica Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Angion Biomedica Corp (ANGN) stock price and investment outlook.

, source: Seeking Alpha

Today, we take our first in-depth look at a small biotech developmental firm that went public just less than a year ago, but is already deep in 'Busted IPO' territory. It popped up on our radars ...

Angion Biomedica Corp Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Angion Biomedica Corp against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Angion Biomedica Corp Stock Forecast

How accurate are Angion Biomedica Corp stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for ANGN predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Angion Biomedica Corp stock price forecasts?

Our analysis considers Angion Biomedica Corp's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Angion Biomedica Corp a good investment in 2025?

Based on our AI analysis, Angion Biomedica Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Angion Biomedica Corp forecasts updated?

Angion Biomedica Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Angion Biomedica Corp Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Angion Biomedica Corp stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...